glycopyrrolate has been researched along with Respiratory Tract Infections in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Castelli, E; Della Bella, G; Vigevano, F | 1 |
| Ferguson, GT; Goodin, T; Kerwin, E; Tosiello, R; Wheeler, A | 1 |
| Burke, C; Chiravuri, D; Malviya, S; Tait, AR; Voepel-Lewis, T; Wagner, D | 1 |
2 trial(s) available for glycopyrrolate and Respiratory Tract Infections
| Article | Year |
|---|---|
Long-term safety of glycopyrrolate/eFlow
Topics: Administration, Inhalation; Aged; Bronchodilator Agents; Cough; Female; Forced Expiratory Volume; Gastrointestinal Diseases; Glycopyrrolate; Headache; Humans; Male; Middle Aged; Muscarinic Antagonists; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Severity of Illness Index; Tiotropium Bromide; Vital Capacity | 2017 |
Glycopyrrolate does not reduce the incidence of perioperative adverse events in children with upper respiratory tract infections.
Topics: Adolescent; Child; Child, Preschool; Female; Glycopyrrolate; Humans; Incidence; Infant; Intraoperative Complications; Male; Respiratory Tract Infections | 2007 |
1 other study(ies) available for glycopyrrolate and Respiratory Tract Infections
| Article | Year |
|---|---|
Long-term efficacy of glycopyrrolate on sialorrhea in Goldenhar syndrome: a case report.
Topics: Child; Female; Glycopyrrolate; Goldenhar Syndrome; Humans; Quality of Life; Respiratory Tract Infections; Sialorrhea | 2022 |